YAL
RDHL

Your Advocates Ltd’s Redhill Biopharma RDHL Stock Holding History

Your Advocates Ltd’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19
Closed -$14 – 236
2026
Q1 		$14 Hold
19
– – ﹤0.01% 230
2025
Q4 		$20 Hold
19
– – ﹤0.01% 235
2025
Q3 		$41 Buy
+19
New +$31 ﹤0.01% 218

Other funds holding RDHL

YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
VWM
Vermillion Wealth Management Rosemount, Minnesota $427M AUM 12.63% 1-Year Est. Return

Your Advocates Ltd's RDHL Position: Q2 2026 in Review

Your Advocates Ltd sold out of Redhill Biopharma (RDHL) in Q2 2026, closing a stake of 19 shares — an estimated $14 sold.

Your Advocates Ltd first reported a position in RDHL in Q3 2025 and held it in 3 quarters. The position peaked at $41 in Q3 2025. 7 funds tracked by Wall St. Rank hold RDHL as of Q2 2026.

  • Your Advocates Ltd reported no remaining Redhill Biopharma position as of Q2 2026 after selling out during the quarter.
  • Your Advocates Ltd sold 19 Redhill Biopharma shares in Q2 2026, an estimated $14.
  • Your Advocates Ltd first reported a position in Redhill Biopharma in Q3 2025 and held it in 3 quarters.
  • Your Advocates Ltd's Redhill Biopharma position peaked at $41 in Q3 2025.
  • 7 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2026.

Based on Your Advocates Ltd's 13F filing for Q2 2026, filed 5 Aug 2026.